Evidence map›Paper›PMID 42165869›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Factors associated with unplanned healthcare encounters in pediatric cancer patients.

Melissa P Beauchemin, L Lee Dupuis, Catherine Aftandilian, Vibhuti Agarwal, Christina Baggott, Scott M Bradfield, Daniel Cannone, Emi H Caywood, Nicole Crellin-Parsons, Jenna Demedis and 19 more

Abstract readRandomized Controlled TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Melissa P BeaucheminColumbia University School of Nursing/Herbert Irving Cancer Center, 560 West 168th Street, New York, NY, 10032, USA. Mmp2123@cumc.columbia.edu.
L Lee DupuisProgram in Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Catherine AftandilianDivision of Pediatric Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University, Palo Alto, CA, USA.
Vibhuti AgarwalNemours Children's Hospital - Florida, Orlando, FL, USA.
Christina BaggottDivision of Pediatric Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University, Palo Alto, CA, USA.
Scott M BradfieldNemours Children's Health - Jacksonville, Jacksonville, FL, USA.
Daniel CannoneChildren's Hospital of Richmond at VCU, Richmond, VA, USA.
Emi H CaywoodNemours Children's Hospital, Delaware, Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders, Wilmington, DE, USA.
Nicole Crellin-ParsonsProgram in Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Jenna DemedisCenter for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA.
David DickensDepartment of Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA, USA.
Adam J EsbenshadeDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
David R FreyerCancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Allison C GrimesPediatric Hematology Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Kara M KellyDepartment of Pediatrics, Roswell Park Comprehensive Cancer Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA.
Allison A KingDivision of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Lisa M KlesgesDivision of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Wade KyonoKapi'olani Medical Center for Women & Children, Honolulu, HI, USA.
Ramamoorthy NagasubramanianNemours Children's Hospital - Florida, Orlando, FL, USA.
Etan OrgelCancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Andrea D OrseyCenter for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, CT, USA.
Michael E RothDepartment of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Farha SheraniDriscoll Children's Hospital, Cancer and Blood Disorders Center and Texas A&M University, Corpus Christi, TX, USA.
Emily VetteseProgram in Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Alexandra WalshCenter for Cancer and Blood Disorders, Phoenix Children's Hospital, Thomas Campus, Phoenix, AZ, USA.
Wendy Woods-SwaffordBlank Cancer and Blood Disorders Center, Blank Children's Hospital- UnityPoint Health, Des Moines, IO, USA.
Lolie C YuLouisiana State University Health Sciences Center/Children's Hospital New Orleans, New Orleans, LA, USA.
George A TomlinsonDepartment of Medicine, Toronto General Hospital, Toronto, Ontario, Canada.
Lillian SungProgram in Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.

Funding

Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized TrialR01CA251112 · NCI · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI DUPUIS, LAURA LEE, GRIMES, ALLISON · 2020 to 2024
$2.3M
NCI NIH HHS R01 CA251112
6 · The paper itself

Abstract

introductionPediatric cancer therapies can cause complications that drive unplanned healthcare encounters (e.g., emergency visits and unplanned admissions). Characterizing their frequency and risk factors is important for resource planning, family counseling, and targeted mitigation strategies. In a secondary analysis of data from a cluster-randomized controlled trial of symptom monitoring in pediatric cancer patients, the primary objective was to describe the characteristics of unplanned healthcare encounters. The secondary objective was to identify risk factors associated with unplanned healthcare encounters.

methodsThis was a sub-analysis of a cluster-randomized trial of 10 sites randomized to symptom screening and 10 sites randomized to usual care. We included English- or Spanish-speaking pediatric patients newly diagnosed with cancer who were 8-18 years of age receiving any cancer treatment. At symptom screening sites, enrolled participants were reminded to complete symptom screening with Symptom Screening in Pediatrics Tool (SSPedi), a validated symptom screening and assessment, three times weekly for 8 weeks. The healthcare team was notified for severely bothersome symptoms. Emergency department visits, and unplanned clinic visits and admissions were determined from families and charts. Encounter documentation was reviewed to determine if the unplanned encounter was related to SSPedi symptoms.

resultsAmong the 444 participants from 20 participating sites, there were 652 unplanned encounters and the most common were emergency room visits (n = 269) followed by unplanned clinic visits (n = 143) and unplanned admissions (n = 240). Pain was the primary reason for emergency room visits (59, 13.3%), unplanned clinic visits (52, 11.7%), and unplanned admissions (19, 4.3%). Nausea/vomiting was the next most common symptom for emergency room visits (40, 9.0%), unplanned clinic visits (4, 0.9%), and unplanned admissions (14, 3.2%). In multivariable analysis, leukemia diagnosis (P = 0.0003), site randomization (P = 0.018), and increasing physician full-time equivalents per 100 new cancer diagnoses (P = 0.032) were associated with more unplanned encounters.

conclusionsUnplanned healthcare utilization is common among newly diagnosed pediatric cancer patients. The association between unplanned healthcare utilization and standardized symptom screening and increasing physical full-time equivalents warrant further investigation. Key aspects to the implementation of routine symptom screening among pediatric patients with cancer will be resource allocation to prevent and manage common symptoms including those that may lead to unplanned healthcare visits.

Indexed as

Emergency Service, HospitalHospitalizationNeoplasmsAdolescentChildEmergency Room VisitsFemaleHumansMaleRisk FactorsClinical trialHealthcare encountersOncologyPediatricRisk factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.